April 28, 2020 / 8:38 PM / a month ago

BRIEF-Neuraptive Therapeutics Reports FDA Clearance Of IND Application For Peripheral Nerve Injuries Treatment NTX-001

April 28 (Reuters) -

* NEURAPTIVE THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR NTX-001, A NOVEL APPROACH FOR THE TREATMENT OF PATIENTS WITH PERIPHERAL NERVE INJURIES Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below